Last $4.08 USD
Change Today -0.1061 / -2.53%
Volume 1.2K
VSCP On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 4:30 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

virtualscopics inc (VSCP) Snapshot

Open
$4.19
Previous Close
$4.19
Day High
$4.19
Day Low
$4.08
52 Week High
08/13/13 - $6.90
52 Week Low
12/12/13 - $2.93
Market Cap
12.2M
Average Volume 10 Days
2.4K
EPS TTM
$-0.85
Shares Outstanding
3.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VIRTUALSCOPICS INC (VSCP)

Related News

No related news articles were found.

virtualscopics inc (VSCP) Related Businessweek News

No Related Businessweek News Found

virtualscopics inc (VSCP) Details

VirtualScopics, Inc. provides imaging solutions for the pharmaceutical, biotechnology, and medical device industries. It offers a suite of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. The company’s software and algorithms provide measurement capabilities to enhance clinical research and development. Its image-based measurement and visualization tools enable automated, accurate, and reproducible measurement of changes that occur in anatomic structures in musculoskeletal, oncological, cardiological, and neurological diseases. The company is headquartered in Rochester, New York.

77 Employees
Last Reported Date: 03/31/14

virtualscopics inc (VSCP) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $60.5K
Acting Chief Financial Officer and Principal ...
Total Annual Compensation: $127.4K
Compensation as of Fiscal Year 2013.

virtualscopics inc (VSCP) Key Developments

VirtualScopics, Inc. Names Eric T. Converse as President and Chief Executive Officer

The Board of Directors of VirtualScopics Inc. announced that Eric T. Converse, 48, has been named president and chief executive officer, effective immediately. Mr. Converse joined the company's Board of Directors in August 2013 and has held the positions of interim president and chief executive officer since October 25, 2013.

IXICO Plc and VirtualScopics Inc. Announce Formation of a Scientific Advisory Board

VirtualScopics Inc. and IXICO Plc jointly announced the formation of a Scientific Advisory Board that will benefit both companies. Dr. Edward Ashton, Ph.D., chief scientific officer, VirtualScopics, will chair the Board which initially will have seven members. The founding members of the Scientific Advisory Board are Dr. Edward Ashton, Ph.D., Chief Scientific Officer, VirtualScopics Inc. (Chair); Dr. Derek Hill, Ph.D., Chief Executive Officer, IXICO plc; Dr. Jonathan Riek, Ph.D., Chief Technical Officer, VirtualScopics Inc.; Dr. Jeffrey Evelhoch, Ph.D., Vice President & Global Head of Imaging in Early Stage Development, Merck Research Laboratories; Dr. Dirk Reitsma, M.D., Vice President of Global Product Development and Therapeutic Area Head of Oncology, PPD; Dr. Claude Sirlin, M.D., Professor of Radiology & Chief of Body Imaging, Department of Radiology, University of California, San Diego; Dr. Karl Schwarz, M.D., University of Rochester.

VirtualScopics Inc. and IXICO Plc Open Operations and Business Development Office in New Hope, PA

VirtualScopics Inc. and IXICO plc announced that they are jointly leasing 2,190 sq. ft. of office space in New Hope, Pennsylvania, strategically located within the big pharma corridor that runs through New Jersey and Pennsylvania. The office will be located at 220 Union Square Drive, located within the Union Square office complex in New Hope. Staffing for the office will begin immediately. This new office will establish a presence for the international commercial and operational alliance VirtualScopics and IXICO have formed. The New Hope office will provide a base of operations for project managers to meet with clinical trial managers, members of the business development team to meet with new and existing clients, as well as for human resource personnel to recruit new talent to support the clients' upcoming clinical trials.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSCP:US $4.08 USD -0.1061

VSCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Covance Inc $85.39 USD -3.59
ICON PLC $52.11 USD +4.21
PAREXEL International Corp $54.78 USD -0.11
View Industry Companies
 

Industry Analysis

VSCP

Industry Average

Valuation VSCP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.2x
Price/Book 1.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIRTUALSCOPICS INC, please visit www.virtualscopics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.